全文获取类型
收费全文 | 3109篇 |
免费 | 178篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 48篇 |
妇产科学 | 20篇 |
基础医学 | 302篇 |
口腔科学 | 51篇 |
临床医学 | 183篇 |
内科学 | 730篇 |
皮肤病学 | 29篇 |
神经病学 | 174篇 |
特种医学 | 96篇 |
外科学 | 918篇 |
综合类 | 17篇 |
预防医学 | 87篇 |
眼科学 | 60篇 |
药学 | 137篇 |
中国医学 | 4篇 |
肿瘤学 | 383篇 |
出版年
2023年 | 22篇 |
2022年 | 40篇 |
2021年 | 65篇 |
2020年 | 54篇 |
2019年 | 60篇 |
2018年 | 60篇 |
2017年 | 70篇 |
2016年 | 64篇 |
2015年 | 77篇 |
2014年 | 101篇 |
2013年 | 97篇 |
2012年 | 143篇 |
2011年 | 183篇 |
2010年 | 92篇 |
2009年 | 102篇 |
2008年 | 174篇 |
2007年 | 133篇 |
2006年 | 128篇 |
2005年 | 124篇 |
2004年 | 107篇 |
2003年 | 113篇 |
2002年 | 131篇 |
2001年 | 92篇 |
2000年 | 79篇 |
1999年 | 86篇 |
1998年 | 39篇 |
1997年 | 35篇 |
1996年 | 35篇 |
1995年 | 38篇 |
1994年 | 31篇 |
1993年 | 18篇 |
1992年 | 59篇 |
1991年 | 76篇 |
1990年 | 83篇 |
1989年 | 68篇 |
1988年 | 67篇 |
1987年 | 60篇 |
1986年 | 62篇 |
1985年 | 46篇 |
1984年 | 43篇 |
1983年 | 41篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1979年 | 20篇 |
1978年 | 12篇 |
1977年 | 13篇 |
1975年 | 3篇 |
1972年 | 3篇 |
1967年 | 4篇 |
1966年 | 9篇 |
排序方式: 共有3299条查询结果,搜索用时 15 毫秒
71.
Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion 总被引:6,自引:0,他引:6
Kimura F Gotoh M Tanaka T Luo Z Miyazaki J Uede T Monden M Miyasaka M 《Diabetologia》2002,45(6):831-840
AIMS/HYPOTHESIS: This study examined whether locally expressed CTLA4-Ig can suppress the accelerated islet allograft rejection that is induced by donor-specific transfusion. METHODS: CTLA4-Ig-transfected or parental MIN6 cells were transplanted subcutaneously into the right flank of streptozotocin-induced diabetic C3H/Hej mice with or without donor-specific transfusion. For donor-specific transfusion, spleen cells from C57BL/6 mice were injected i.v. at the time of transplantation. In other experiments, CTLA4-Ig-transfected and parental MIN6 cells were transplanted separately into each flank, together with donor-specific transfusion. Rejection was defined as a blood glucose concentration of more than 300 mg/dl in two consecutive measurements, and graft survival was confirmed by hyperglycaemia after the grafts were removed. The effect of an anti-CTLA4 antibody on the survival of CTLA4-Ig-transfected MIN6 cells was also examined. RESULTS: In 7 of 12 donor-specific transfusion sensitised mice, CTLA4-Ig-transfected MIN6 cells remained viable 20 days after grafting, whereas all parental MIN6 cells ( n = 10) were rejected promptly, within 14 days. The prolonged allograft survival was observed even in the absence of detectable levels of serum CTLA4-Ig, while the surviving allografts continued to produce CTLA4-Ig in situ. This protection was abrogated by an anti-CTLA4 antibody, but not by a control antibody. Furthermore, six animals that maintained normoglycaemia after the separate transplantation of parental and CTLA4-Ig-transfected MIN6 cells into each flank all showed abrupt hyperglycaemia after the CTLA4-Ig/MIN6 graft was removed, suggesting that this protection operated locally. CONCLUSION/INTERPRETATION: A beta-cell line genetically engineered to secrete CTLA4-Ig can protect a graft locally from the alloimmune response induced by donor-specific transfusion. 相似文献
72.
K Mizuno M Gotoh S Nagasawa J Matsui T Toki S Hashimoto S Fukuchi 《Japanese circulation journal》1983,47(10):1203-1209
1) Renin-like enzyme of rat aorta was purified by chromatography with DEAE-cellulose and Sephadex G-200. 2) The molecular weight of renin-like enzyme was 124,000 and 72,000 on Sephadex G-200 gel filtration. The isozymes, however, migrated as a single band with molecular weight of 71,000 on SDS/polyacrylamide gel electrophoresis. These isozymes showed the same optimal pH (6.5) and temperature (37 degrees C). 3) Renin-like enzyme showed high activity in the microsomal fraction of the aorta. 4) In one-clip, two-kidney Goldblatt hypertensive rats, the aortic renin concentration increased significantly, but not parallel with the activity in plasma. 5) Renin, widely distributed in subcellular fractions of the aorta, may play a possible role in the local control of vascular tone. It is likely that renin in vascular wall is of local origin. 相似文献
73.
Ohga S Kubo E Nomura A Takada H Suga N Ishii E Suminoe A Inamitsu T Matsuzaki A Kasuga N Hara T 《International journal of hematology》2001,73(3):323-326
Epstein-Barr virus (EBV)-DNA was quantitatively measured to assess posttransplantation virus reactivation by real-time polymerase chain reaction (PCR). In the first retrospective analysis of a 7-year-old boy with lymphoproliferative disease (LPD) after an unrelated cord blood transplantation, serum EBV-DNA progressively increased to 4 x 10(5) copies/mL. EBV load was then prospectively monitored in peripheral blood from posttransplantation patients. The second case was an 8 year-old boy with aplastic anemia who received a CD34+ cell transplantation. This patient died of LPD with the progression of pulmonary nodules. EBV-DNA increased to 4 x 10(4) copies/mL after the control of cytomegalovirus reactivation. On the other hand, EBV-DNA was undetectable (<200 copies/mL) in the series of all 58 samples from 10 patients who did not develop LPD after hematopoietic stem cell transplantation. Sequential monitoring of circulating EBV-DNA by quantitative PCR may be a useful indicator for predicting the development of posttransplantation LPD. 相似文献
74.
75.
Wenxin Ma Radu Cojocaru Norimoto Gotoh Linn Gieser Rafael Villasmil Tiziana Cogliati Anand Swaroop Wai T. Wong 《Neurobiology of aging》2013
Microglia, the resident immune cells of the central nervous system (CNS), are thought to contribute to the pathogenesis of age-related neurodegenerative disorders. It has been hypothesized that microglia undergo age-related changes in gene expression patterns that give rise to pathogenic phenotypes. We compared the gene expression profiles in microglia isolated ex vivo from the retinas of mice ranging from early adulthood to late senescence. We discovered that microglial gene expression demonstrated progressive change with increasing age, and involved genes that regulate microglial supportive functions and immune activation. Molecular pathways involving immune function and regulation, angiogenesis, and neurotrophin signaling demonstrated age-related change. In particular, expression levels of complement genes, C3 and CFB, previously associated with age-related macular degeneration (AMD), increased with aging, suggesting that senescent microglia may contribute to complement dysregulation during disease pathogenesis. Taken together, senescent microglia demonstrate age-related gene expression changes capable of altering their constitutive support functions and regulation of their activation status in ways relating to neuroinflammation and neurodegeneration in the CNS. 相似文献
76.
Influence of E. coli‐induced prostatic inflammation on expression of androgen‐responsive genes and transforming growth factor beta 1 cascade genes in rats
下载免费PDF全文
![点击此处可从《The Prostate》网站下载免费的PDF全文](/ch/ext_images/free.gif)
77.
Polygenic expression of teratozoospermia and normal fertility in B10.MOL‐TEN1 mouse strain
下载免费PDF全文
![点击此处可从《Congenital anomalies》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Keitaro Hirawatari Naoto Hanzawa Maki Kuwahara Hiroaki Aoyama Ikuo Miura Shigeharu Wakana Hideo Gotoh 《Congenital anomalies》2015,55(2):92-98
Subfertility and infertility are two major reproductive health problems in human and domestic animals. The contribution of the genotype to these conditions is poorly understood. To examine the genetic basis of male subfertility, we analyzed its relationship to sperm morphology in B10.MOL‐TEN1 mice, which shows high‐frequencies (about 50%) of morphologically abnormal sperm. Drastic histological changes were also found in the testis of the B10.MOL‐TEN1. Segregation analysis showed that the abnormal sperm phenotype in B10.MOL‐TEN1 was inherited and was predictably controlled by at least three loci. We also found that male fertility of this strain was normal. These findings indicate a complicated relationship between sperm morphology and male subfertility. 相似文献
78.
79.
Masao Omata Shuhei Nishiguchi Yoshiyuki Ueno Hitoshi Mochizuki Namiki Izumi Fusao Ikeda Hidenori Toyoda Osamu Yokosuka Kazushige Nirei Takuya Genda Takeji Umemura Tetsuo Takehara Naoya Sakamoto Yoichi Nishigaki Kunio Nakane Nobuo Toda Tatsuya Ide Mikio Yanase Keisuke Hino Bing Gao Kimberly L. Garrison Hadas Dvory‐Sobol Akinobu Ishizaki Masa Omote Diana Brainard Steven Knox William T. Symonds John G. McHutchison Hiroshi Yatsuhashi Masashi Mizokami 《Journal of viral hepatitis》2014,21(11):762-768
Genotype 2 hepatitis C virus (HCV) accounts for up to 30% of chronic HCV infections in Japan. The standard of care for patients with genotype 2 HCV – peginterferon and ribavirin for 24 weeks – is poorly tolerated, especially among older patients and those with advanced liver disease. We conducted a phase 3, open‐label study to assess the efficacy and safety of an all‐oral combination of the NS5B polymerase inhibitor sofosbuvir and ribavirin in patients with chronic genotype 2 HCV infection in Japan. We enrolled 90 treatment‐naïve and 63 previously treated patients at 20 sites in Japan. All patients received sofosbuvir 400 mg plus ribavirin (weight‐based dosing) for 12 weeks. The primary endpoint was sustained virologic response at 12 weeks after therapy (SVR12). Of the 153 patients enrolled and treated, 60% had HCV genotype 2a, 11% had cirrhosis, and 22% were over the aged 65 or older. Overall, 148 patients (97%) achieved SVR12. Of the 90 treatment‐naïve patients, 88 (98%) achieved SVR12, and of the 63 previously treated patients, 60 (95%) achieved SVR12. The rate of SVR12 was 94% in patients with cirrhosis and in those aged 65 and older. No patients discontinued study treatment due to adverse events. The most common adverse events were nasopharyngitis, anaemia and headache. Twelve weeks of sofosbuvir and ribavirin resulted in high rates of SVR12 in treatment‐naïve and previously treated patients with chronic genotype 2 HCV infection. The treatment was safe and well tolerated by patients, including the elderly and those with cirrhosis. 相似文献
80.
Masamitsu Ubukata Isao Ohsawa Hiroki Suzuki Rin Asao Yuya Nakamura Hirofumi Nishida Masayuki Nakamura Kosaku Nitta Yoshikazu Goto Hiromichi Gotoh 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(4):393-399
Ceftriaxone‐associated biliary pseudolithiasis is common among children; however, there are only a few reports of pseudolithiasis in adult patients on HD. This retrospective cohort study included 278 adult patients on ceftriaxone therapy from 1 February 2016 to 1 September 2018. Pseudolithiasis was defined as a new development of sludge or stones in the gallbladder within 60 days of ceftriaxone therapy. After excluding patients with preexisting gallstones and a history of cholecystectomy, 113 patients on maintenance HD, and another 98 patients were enrolled as the HD and control group, respectively. Thirteen patients developed pseudolithiasis. Its incidence was significantly higher in the HD group than that in the control group. Multivariate logistic regression analyses showed that development of pseudolithiasis was significantly associated with HD and ceftriaxone dose. Therefore, HD in patients receiving ceftriaxone therapy appears to be associated with a risk of pseudolithiasis. These findings highlight the need for careful follow‐up. 相似文献